Follow the 파마리서치 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 파마리서치 has published 31 reports. Market capitalisation: €3,870.1bn. The latest transaction was filed on 9 April 2026 (Purchase). Among the most active insiders: PolishCompanyLimited. All data is openly available.
31
Insider Decl.
n/a
Thresholds
€58,404
6 ops.
Buy Volume
n/a
11 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 파마리서치 Strong Buy (bullish), based on 14 analysts. Average price target: ₩490,500.
11Σ signal
Buys €58,404n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 4,116 of 29,063 companies
70.6
score / 100
Value
49
Quality
92
FCF yld3.6%
Earn yld4.0%
EV/EBITDA16.9x
ROE27%
Gross mgn77%
Net mgn31%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
파마리서치 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on the research and development of innovative pharmaceutical solutions.